Therapeutic effects of hepatocyte transplantation via two different intrasplenic approaches in acute hepatic failure rats

doi:10.3969/j.issn.2095-4344.1624

Abstract

Abstract:

BACKGROUND: Hepatocyte transplantation has achieved some success in animal experiments for the treatment of metabolic diseases and acute liver failure. However, the clinical efficacy of hepatocyte transplantation is unsatisfactory. The difference between the experimental results and the clinical efficacy may be related to the hepatocyte transplantation approach.
OBJECTIVE: To evaluate the therapeutic effects of hepatocyte transplantation by the intubation via the intubation of the splenic artery and intrasplenic injection in rats with acute hepatic failure, providing more optimal transplantation approaches and methods.
METHODS: Hepatocytes were isolated and cultured by the modified Seglen’s method (two-step). Acute hepatic failure was induced by D-gal in Sprague-Dawley rats (provided by the Experimental Animal Center of Chongqing Medical University in China). After 24 hours, an intubation tube was inserted into the splenic artery in 65 rats with acute hepatic failure, which was successful in 60 rats. Then these 60 rat models were randomly divided into three groups (n=20 per group). Intrasplenic injection group received about 2×10⁷ hepatocytes through intrasplenic injection and 0.4 mL of Hank’s solution through the splenic artery. Splenic artery group received 0.4 mL of Hank’s solution through intrasplenic injection and 2×10⁷ hepatocytes through the splenic artery. Model group received 0.4 mL of Hank’s solution through intrasplenic injection and 0.4 mL of Hank’s solution through the splenic artery. Survival rate and liver function of the rats was observed within 14 days after transplantation. The distribution of CFDA-SE-labeled hepatocytes transplanted via the splenic artery was observed under fluorescence microscope at 7 days after transplantation, and meanwhile, the distribution and proliferation of transplanted hepatocytes in the spleen were observed using hematoxylin-eosin staining. Synthesis of albumin in the spleen was observed by immunofluorescence staining.
RESULTS AND CONCLUSION: (1) 80%-90% hepatocytes survived after isolation. (2) At 14 days after transplantation, the survival rates of rats in the three groups were significantly different: intrasplenic injection group > splenic artery group > model group. (3) The liver function of rats was significantly improved in the intrasplenic injection group and the splenic artery group, especially in the former group. (4) CFDA-SE-labeled hepatocytes (green fluorescence) were scattered in the rat spleen and liver at 7 days after transplantation via the splenic artery. (5) At 14 days after transplantation, immunofluorescent staining of albumin demonstrated some positive cells in the rat spleen in the intrasplenic injection group and splenic artery group. (6) At 7 days after transplantation, transplanted hepatocytes were concentrated and colonized in the red pulp of the spleen. In conclusion, hepatocyte transplantation through catheterization of the splenic artery via carotid route can improve the survival of rats with acute hepatic failure and ameliorate the hepatic function, but intrasplenic injection is significantly superior to the injection via the splenic artery.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

Key words: Liver Failure, Acute, Hepatocytes, Spleen, Splenic Artery, Tissue Engineering

CLC Number:

Feng Yuan, Li Dewei, Yang Junjun. Therapeutic effects of hepatocyte transplantation via two different intrasplenic approaches in acute hepatic failure rats[J]. Chinese Journal of Tissue Engineering Research, 2019, 23(9): 1422-1427.

Figures/Tables 7

References

[1] Newland CD. Acute Liver Failure. Pediatr Ann. 2016;45(12): e433-e438.

[2] Sarin SK, Choudhury A. Acute-on-chronic Liver Failure. Curr Gastroenterol Rep. 2016;18(12):61.

[3] Dhawan A.Clinical human hepatocyte transplantation: Current status and challenges. Liver Transpl. 2015;21 Suppl 1:S39-44.

[4] Patel P, Okoronkwo N, Pyrsopoulos NT. Future Approaches and Therapeutic Modalities for Acute Liver Failure. Clin Liver Dis. 2018;22(2):419-427.

[5] Thawley V. Acute Liver Injury and Failure. Vet Clin North Am Small Anim Pract. 2017;47(3):617-630.

[6] Soltys KA, Setoyama K, Tafaleng EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66(5):987-1000.

[7] Iansante V, Mitry RR, Filippi C, et al. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res. 2018;83(1-2):232-240.

[8] Khan Z, Strom SC. Hepatocyte Transplantation in Special Populations: Clinical Use in Children. Methods Mol Biol. 2017; 1506:3-16.

[9] Zern MA. Cell transplantation to replace whole liver transplantation. Gastroenterology. 2009;136(3):767-769.

[10] Kobayashi E, Enosawa S, Nagashima H. Experimental Hepatocyte Transplantation in Pigs. Methods Mol Biol. 2017; 1506:149-160.

[11] Pietrosi G, Vizzini GB, Gruttadauria S, et al. Clinical applications of hepatocyte transplantation. World J Gastroenterol. 2009;15(17): 2074-2077.

[12] Nagata H, Ito M, Shirota C, et al. Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation. 2003;76(4):732-734.

[13] Iwase H, Liu H, Schmelzer E, et al. Transplantation of hepatocytes from genetically engineered pigs into baboons. Xenotransplantation. 2017;24(2): 1-22.

[14] Soltys KA, Setoyama K, Tafaleng EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66(5):987-1000.

[15] Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29-83.

[16] 冯渊,李德卫,杨晓波,等.原发肝细胞的分离和移植[J].中国组织工程研究,2012,16(18):3314-3317.

[17] 冯渊,李德卫,杨均均,等.经大鼠脾动脉行肝细胞移植建立动物模型[J].复旦学报(医学版),2012,39(6):653-657.

[18] Puppi J, Strom SC, Hughes RD, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant. 2012;21(1):1-10.

[19] Hansel MC, Gramignoli R, Skvorak KJ, et al. The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol. 2014;62: 14.12.1-14.12.23.

[20] Kluge M, Reutzel-Selke A, Napierala H, et al. Human Hepatocyte Isolation: Does Portal Vein Embolization Affect the Outcome. Tissue Eng Part C Methods. 2016;22(1):38-48.

[21] Moris D, Vernadakis S, Papalampros A, et al. Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol. 2016;22(33):7613-7624.

[22] Dagher I, Boudechiche L, Branger J, et al. Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization. Transplantation. 2006;82(8):1067-1073.

[23] Timm F, Vollmar B. Heterogeneity of the intrahepatic portal venous blood flow: impact on hepatocyte transplantation. Microvasc Res. 2013;86:34-41.

[24] Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis. 1999;19(1): 39-48.

[25] Dhawan A, Puppi J, Hughes RD, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7(5):288-298.

[26] Ho CM, Chen YH, Chien CS, et al. Transplantation speed offers early hepatocyte engraftment in acute liver injured rats: A translational study with clinical implications. Liver Transpl. 2015; 21(5):652-661.

[27] Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transpl. 2000;6(1):32-40.

[28] Wang F, Zhou L, Ma X, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study. Transplant Proc. 2014;46(1):192-198.

[29] Nordlinger B, Bouma ME, Wang SR, et al. High-yield preparation of porcine hepatocytes for long survival after transplantation in the spleen. Eur Surg Res. 1985;17(6):377-382.

[30] Fox IJ, Roy-Chowdhury J. Hepatocyte transplantation. J Hepatol. 2004;40(6):878-886.

[31] Gäbelein G, Nüssler AK, Morgott F, et al. Intrasplenic or subperitoneal hepatocyte transplantation to increase survival after surgically induced hepatic failure. Eur Surg Res. 2008;41(3): 253-259.

[32] Koblihová E, Lukšan O, Mrázová I, et al. Hepatocyte transplantation attenuates the course of acute liver failure induced by thioacetamide in Lewis rats. Physiol Res. 2015;64(5):689-700.

[33] 李宏涛,陈国民. D-氨基半乳糖研究的回顾和展望[J] .肝脏, 2004, 9(3):209-210.

[34] 冯渊,李德卫,杨晓波,等.经颈动脉途径肝动脉插管及脾内注射肝细胞移植治疗急性肝衰大鼠的疗效比较[J].重庆医科大学学报, 2012, 37(1):84-88.